(-)-demecolcine increases expression ISO BCL2L11 (Homo sapiens) 6480464 Demecolcine results in increased expression of BCL2L11 mRNA CTD PMID:23649840 (S)-amphetamine multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [N-Methyl-3 more ... CTD PMID:23820845 (S)-amphetamine increases expression ISO BCL2L11 (Homo sapiens) 6480464 Dextroamphetamine results in increased expression of BCL2L11 mRNA and Dextroamphetamine results in increased expression of BCL2L11 protein CTD PMID:23820845 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o more ... CTD PMID:22937105 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o and p'-DDT analog results in decreased expression of BCL2L11 mRNA CTD PMID:22937105 1,1-dichloroethene increases expression ISO Bcl2l11 (Mus musculus) 6480464 vinylidene chloride results in increased expression of BCL2L11 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO Bcl2l11 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of BCL2L11 mRNA CTD PMID:22206623 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-4-piperidinol multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 dorsomorphin inhibits the reaction [Penfluridol results in increased expression of BCL2L11 mRNA] more ... CTD PMID:35530161 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-4-piperidinol increases expression ISO BCL2L11 (Homo sapiens) 6480464 Penfluridol results in increased expression of BCL2L11 mRNA and Penfluridol results in increased expression of BCL2L11 protein CTD PMID:35530161 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of BCL2L11 mRNA CTD PMID:30723492 17beta-estradiol affects expression ISO BCL2L11 (Homo sapiens) 6480464 Estradiol affects the expression of BCL2L11 mRNA CTD PMID:21826169 17beta-estradiol increases expression ISO BCL2L11 (Homo sapiens) 6480464 Estradiol results in increased expression of BCL2L11 mRNA CTD PMID:23373633 more ... 1H-pyrazole increases expression ISO Bcl2l11 (Mus musculus) 6480464 pyrazole results in increased expression of BCL2L11 mRNA CTD PMID:17945193 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 2 more ... CTD PMID:21851831 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO BCL2L11 (Homo sapiens) 6480464 2 more ... CTD PMID:27589474 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2L11 mRNA CTD PMID:19520675 and PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BCL2L11 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Bcl2l11 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2L11 mRNA CTD PMID:15800033 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Bcl2l11 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of BCL2L11 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 2 more ... CTD PMID:21851831 and PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2L11 mRNA CTD PMID:19770486 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Trinitrobenzenesulfonic Acid results in increased expression of MAPK9 protein] promotes the reaction [BCL2L11 protein binds to MAPK9 protein] more ... CTD PMID:22427801 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Bcl2l11 (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of BCL2L11 protein CTD PMID:22427801 2-butoxyethanol increases expression ISO Bcl2l11 (Mus musculus) 6480464 n-butoxyethanol results in increased expression of BCL2L11 mRNA CTD PMID:19812364 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of BCL2L11 mRNA CTD PMID:19643169 2-palmitoylglycerol increases expression ISO BCL2L11 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of BCL2L11 mRNA CTD PMID:37199045 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,4-methylenedioxymethamphetamine multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [N-Methyl-3 more ... CTD PMID:23820845 3,4-methylenedioxymethamphetamine increases expression ISO BCL2L11 (Homo sapiens) 6480464 N-Methyl-3 more ... CTD PMID:23820845 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L11 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol affects methylation ISO Bcl2l11 (Mus musculus) 6480464 bisphenol S affects the methylation of BCL2L11 gene CTD PMID:31683443 4-hydroxynon-2-enal increases expression ISO Bcl2l11 (Mus musculus) 6480464 4-hydroxy-2-nonenal results in increased expression of BCL2L11 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO Bcl2l11 (Mus musculus) 6480464 Fenretinide results in increased expression of BCL2L11 mRNA CTD PMID:28973697 4-nitrophenol increases expression ISO Bcl2l11 (Mus musculus) 6480464 4-nitrophenol results in increased expression of BCL2L11 mRNA CTD PMID:34673133 4-nonylphenol increases expression EXP 6480464 4-nonylphenol results in increased expression of BCL2L11 protein CTD PMID:26804764 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of BCL2L11 protein] CTD PMID:34214594 4-vinylcyclohexene dioxide affects expression ISO Bcl2l11 (Mus musculus) 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of BCL2L11 mRNA CTD PMID:20829426 5-aza-2'-deoxycytidine increases expression ISO BCL2L11 (Homo sapiens) 6480464 Decitabine results in increased expression of BCL2L11 mRNA and Decitabine results in increased expression of BCL2L11 protein CTD PMID:19403302 5-aza-2'-deoxycytidine decreases methylation ISO BCL2L11 (Homo sapiens) 6480464 Decitabine results in decreased methylation of BCL2L11 promoter CTD PMID:19403302 5-fluorouracil multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 Fluorouracil affects the reaction [rebamipide results in decreased expression of BCL2L11 protein] and rebamipide inhibits the reaction [Fluorouracil results in increased expression of BCL2L11 protein] CTD PMID:29054700 5-fluorouracil increases expression ISO BCL2L11 (Homo sapiens) 6480464 Fluorouracil results in increased expression of BCL2L11 protein CTD PMID:29054700 7-ketocholesterol affects localization ISO BCL2L11 (Homo sapiens) 6480464 7-ketocholesterol affects the localization of BCL2L11 protein CTD PMID:15955068 8-(4-chlorophenylthio)-cAMP increases expression ISO Bcl2l11 (Mus musculus) 6480464 8-((4-chlorophenyl)thio)cyclic-3' more ... CTD PMID:14996839 8-(4-chlorophenylthio)-cAMP increases response to substance ISO Bcl2l11 (Mus musculus) 6480464 BCL2L11 protein results in increased susceptibility to 8-((4-chlorophenyl)thio)cyclic-3' and 5'-AMP CTD PMID:14996839 8-(4-chlorophenylthio)-cAMP increases response to substance ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 protein results in increased susceptibility to 8-((4-chlorophenyl)thio)cyclic-3' and 5'-AMP CTD PMID:14996839 8-(4-chlorophenylthio)-cAMP increases expression ISO BCL2L11 (Homo sapiens) 6480464 8-((4-chlorophenyl)thio)cyclic-3' and 5'-AMP results in increased expression of BCL2L11 protein CTD PMID:14996839 8-Br-cAMP multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of BCL2L11 protein CTD PMID:16709600 9,10-anthraquinone increases expression ISO BCL2L11 (Homo sapiens) 6480464 9 and 10-anthraquinone analog results in increased expression of BCL2L11 protein CTD PMID:26915975 9-cis-retinoic acid increases expression ISO BCL2L11 (Homo sapiens) 6480464 Alitretinoin results in increased expression of BCL2L11 protein CTD PMID:16340750 9-cis-retinoic acid multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 seocalcitol inhibits the reaction [Alitretinoin results in increased expression of BCL2L11 protein] CTD PMID:16340750 ABT-737 multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [ABT-737 inhibits the reaction [BCL2L11 protein binds to BCL2 protein]] promotes the reaction [BCL2L11 protein results in increased activity of BAX protein] more ... CTD PMID:17097560 more ... ABT-737 increases response to substance ISO Bcl2l11 (Mus musculus) 6480464 BCL2L11 protein results in increased susceptibility to ABT-737 CTD PMID:20038611 acetylsalicylic acid increases expression ISO BCL2L11 (Homo sapiens) 6480464 Aspirin results in increased expression of BCL2L11 mRNA CTD PMID:19936928 acrolein multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BCL2L11 mRNA more ... CTD PMID:32699268 and PMID:32845096 actinomycin D multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of BCL2L11 mRNA] CTD PMID:16166651 aflatoxin B1 increases expression ISO Bcl2l11 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of BCL2L11 mRNA CTD PMID:19770486 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of BCL2L11 mRNA CTD PMID:25378103 and PMID:33354967 aldehydo-D-glucose multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] and resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] CTD PMID:25471227 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of BCL2L11 protein CTD PMID:25471227 all-trans-retinoic acid decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Tretinoin results in decreased expression of BCL2L11 protein CTD PMID:19176369 all-trans-retinoic acid increases expression ISO BCL2L11 (Homo sapiens) 6480464 Tretinoin results in increased expression of BCL2L11 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BCL2L11 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of BCL2L11 mRNA CTD PMID:32699268 amiodarone increases expression ISO BCL2L11 (Homo sapiens) 6480464 Amiodarone results in increased expression of BCL2L11 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BCL2L11 mRNA CTD PMID:16483693 ammonium chloride increases expression ISO Bcl2l11 (Mus musculus) 6480464 Ammonium Chloride results in increased expression of BCL2L11 mRNA CTD PMID:31310755 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 pyrazolanthrone inhibits the reaction [sodium arsenite results in increased expression of BCL2L11 protein] CTD PMID:16166651 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [docetaxel results in increased degradation of BCL2L11 protein] more ... CTD PMID:17317842 more ... antirheumatic drug decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of BCL2L11 mRNA CTD PMID:24449571 Aroclor 1254 increases expression ISO Bcl2l11 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2L11 mRNA CTD PMID:25270620 arsenous acid increases expression ISO BCL2L11 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of BCL2L11 mRNA and Arsenic Trioxide results in increased expression of BCL2L11 protein CTD PMID:17203211 more ... arsenous acid affects expression ISO BCL2L11 (Homo sapiens) 6480464 Arsenic Trioxide affects the expression of BCL2L11 protein CTD PMID:36509116 arsenous acid increases degradation ISO BCL2L11 (Homo sapiens) 6480464 Arsenic Trioxide results in increased degradation of BCL2L11 protein CTD PMID:36509116 arsenous acid multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased degradation of BCL2L11 protein] more ... CTD PMID:21655183 more ... asbestos decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Asbestos results in decreased expression of BCL2L11 CTD PMID:27042963 Azaspiracid decreases expression ISO BCL2L11 (Homo sapiens) 6480464 azaspiracid results in decreased expression of BCL2L11 mRNA CTD PMID:28939011 azoxystrobin decreases expression ISO BCL2L11 (Homo sapiens) 6480464 azoxystrobin results in decreased expression of BCL2L11 mRNA CTD PMID:33512557 belinostat increases expression ISO BCL2L11 (Homo sapiens) 6480464 belinostat results in increased expression of BCL2L11 protein CTD PMID:18223231 benzo[a]pyrene increases expression ISO BCL2L11 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of BCL2L11 mRNA CTD PMID:15735009 benzo[a]pyrene increases methylation ISO BCL2L11 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of BCL2L11 3' UTR and Benzo(a)pyrene results in increased methylation of BCL2L11 5' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO BCL2L11 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of BCL2L11 promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO Bcl2l11 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of BCL2L11 3' UTR more ... CTD PMID:27901495 benzo[a]pyrene increases methylation ISO Bcl2l11 (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of BCL2L11 gene CTD PMID:28476633 benzo[a]pyrene decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of BCL2L11 mRNA CTD PMID:26238291 benzo[a]pyrene increases expression ISO Bcl2l11 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of BCL2L11 mRNA CTD PMID:19770486 and PMID:21715664 benzo[a]pyrene decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of BCL2L11 mRNA CTD PMID:20713471 benzo[b]fluoranthene increases expression ISO Bcl2l11 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of BCL2L11 protein CTD PMID:21392559 berberine multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Berberine co-treated with Niacinamide] results in increased expression of BCL2L11 mRNA CTD PMID:26712469 berberine increases expression ISO BCL2L11 (Homo sapiens) 6480464 Berberine results in increased expression of BCL2L11 mRNA CTD PMID:26712469 bis(2-chloroethyl) sulfide increases expression ISO Bcl2l11 (Mus musculus) 6480464 Mustard Gas results in increased expression of BCL2L11 mRNA CTD PMID:18955075 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of BCL2L11 mRNA and Diethylhexyl Phthalate results in increased expression of BCL2L11 protein CTD PMID:22610992 and PMID:37979351 bisphenol A affects expression ISO BCL2L11 (Homo sapiens) 6480464 bisphenol A affects the expression of BCL2L11 mRNA CTD PMID:21826169 bisphenol A multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L11 mRNA CTD PMID:28628672 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of BCL2L11 gene CTD PMID:28505145 bisphenol A increases methylation ISO Bcl2l11 (Mus musculus) 6480464 bisphenol A results in increased methylation of BCL2L11 promoter CTD PMID:27312807 bisphenol A increases expression ISO Bcl2l11 (Mus musculus) 6480464 bisphenol A results in increased expression of BCL2L11 mRNA and bisphenol A results in increased expression of BCL2L11 protein CTD PMID:24909818 and PMID:32407858 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BCL2L11 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO BCL2L11 (Homo sapiens) 6480464 bisphenol A results in increased methylation of BCL2L11 gene CTD PMID:22576693 bisphenol A decreases expression ISO BCL2L11 (Homo sapiens) 6480464 bisphenol A results in decreased expression of BCL2L11 mRNA CTD PMID:22576693 bortezomib multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Bortezomib co-treated with romidepsin] results in increased expression of BCL2L11 protein more ... CTD PMID:15173094 and PMID:36509116 bortezomib increases expression ISO BCL2L11 (Homo sapiens) 6480464 Bortezomib results in increased expression of BCL2L11 protein CTD PMID:16024631 more ... bortezomib increases activity ISO BCL2L11 (Homo sapiens) 6480464 Bortezomib results in increased activity of BCL2L11 protein CTD PMID:16446371 bortezomib increases response to substance ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 results in increased susceptibility to Bortezomib CTD PMID:18566236 Brevetoxin B increases expression ISO BCL2L11 (Homo sapiens) 6480464 brevetoxin 2 results in increased expression of BCL2L11 mRNA CTD PMID:20498034 cadmium dichloride increases expression ISO BCL2L11 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of BCL2L11 CTD PMID:21787858 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of BCL2L11 protein CTD PMID:28457857 calcitriol decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Calcitriol results in decreased expression of BCL2L11 mRNA CTD PMID:12071473 carbamazepine affects expression ISO BCL2L11 (Homo sapiens) 6480464 Carbamazepine affects the expression of BCL2L11 mRNA CTD PMID:24752500 carbaryl decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Carbaryl results in decreased expression of BCL2L11 mRNA CTD PMID:27829164 carbon nanotube increases expression ISO Bcl2l11 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of BCL2L11 mRNA CTD PMID:25554681 chlorpyrifos increases expression ISO Bcl2l11 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of BCL2L11 mRNA CTD PMID:27737797 chlorpyrifos multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 Chlorpyrifos promotes the reaction [Streptozocin results in increased expression of BCL2L11 mRNA] CTD PMID:33524429 chromium(6+) increases expression ISO BCL2L11 (Homo sapiens) 6480464 chromium hexavalent ion results in increased expression of BCL2L11 mRNA CTD PMID:17382205 chromium(6+) multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA and Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA] CTD PMID:35643323 chromium(6+) affects expression ISO Bcl2l11 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of BCL2L11 mRNA CTD PMID:28472532 cisplatin multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of BCL2L11 mRNA more ... CTD PMID:21092744 and PMID:27392435 cisplatin increases expression ISO BCL2L11 (Homo sapiens) 6480464 Cisplatin results in increased expression of BCL2L11 mRNA CTD PMID:21092744 and PMID:27392435 clofibrate multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of BCL2L11 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BCL2L11 mRNA] CTD PMID:17585979 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of BCL2L11 mRNA CTD PMID:24386269 cobalt dichloride multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [cobaltous chloride co-treated with lipopolysaccharide more ... CTD PMID:32408695 cobimetinib increases expression ISO BCL2L11 (Homo sapiens) 6480464 cobimetinib results in increased expression of BCL2L11 protein and cobimetinib results in increased expression of BCL2L11 protein alternative form CTD PMID:22084396 cobimetinib multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3 more ... CTD PMID:22084396 cocaine increases expression EXP 6480464 Cocaine results in increased expression of BCL2L11 mRNA CTD PMID:16076954 copper atom multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in increased cleavage of BCL2L11 protein and [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of BCL2L11 protein CTD PMID:22276220 copper(0) multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in increased cleavage of BCL2L11 protein and [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of BCL2L11 protein CTD PMID:22276220 crizotinib increases expression ISO BCL2L11 (Homo sapiens) 6480464 crizotinib results in increased expression of BCL2L11 protein CTD PMID:22729845 crizotinib multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 protein affects the reaction [crizotinib results in increased cleavage of CASP3 protein] and MET gene mutant form promotes the reaction [crizotinib results in increased expression of BCL2L11 protein] CTD PMID:22729845 crizotinib affects response to substance ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 protein affects the susceptibility to crizotinib CTD PMID:22729845 crocidolite asbestos decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of BCL2L11 mRNA CTD PMID:18687144 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of BCL2L11 mRNA CTD PMID:25704630 curcumin increases expression ISO BCL2L11 (Homo sapiens) 6480464 Curcumin results in increased expression of BCL2L11 mRNA CTD PMID:17332930 curcumin multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [arsenic trioxide co-treated with Curcumin] results in increased expression of BCL2L11 protein CTD PMID:27430728 cyclophosphamide multiple interactions EXP 6480464 sacubitril and valsartan sodium hydrate drug combination inhibits the reaction [Cyclophosphamide results in increased expression of BCL2L11 mRNA] and Valsartan inhibits the reaction [Cyclophosphamide results in increased expression of BCL2L11 mRNA] CTD PMID:32197949 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of BCL2L11 mRNA CTD PMID:32197949 D-glucose multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] and resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] CTD PMID:25471227 D-glucose increases expression EXP 6480464 Glucose results in increased expression of BCL2L11 protein CTD PMID:25471227 dactolisib affects expression ISO BCL2L11 (Homo sapiens) 6480464 dactolisib affects the expression of BCL2L11 protein CTD PMID:25640480 dantrolene multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 Dantrolene inhibits the reaction [Halothane results in increased expression of BCL2L11 mRNA] CTD PMID:32795494 DDE affects expression EXP 6480464 Dichlorodiphenyl Dichloroethylene affects the expression of BCL2L11 mRNA CTD PMID:24576310 deguelin decreases expression ISO BCL2L11 (Homo sapiens) 6480464 deguelin results in decreased expression of BCL2L11 mRNA CTD PMID:33512557 dexamethasone increases response to substance ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 protein results in increased susceptibility to Dexamethasone CTD PMID:14996839 dexamethasone increases response to substance ISO Bcl2l11 (Mus musculus) 6480464 BCL2L11 protein results in increased susceptibility to Dexamethasone CTD PMID:14996839 dexamethasone increases expression ISO Bcl2l11 (Mus musculus) 6480464 Dexamethasone results in increased expression of BCL2L11 mRNA alternative form and Dexamethasone results in increased expression of BCL2L11 protein CTD PMID:14996839 and PMID:17953376 dexamethasone multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L11 mRNA more ... CTD PMID:18515658 more ... dexamethasone increases phosphorylation ISO BCL2L11 (Homo sapiens) 6480464 Dexamethasone results in increased phosphorylation of BCL2L11 protein CTD PMID:20067466 dexamethasone increases expression ISO BCL2L11 (Homo sapiens) 6480464 Dexamethasone results in increased expression of BCL2L11 mRNA CTD PMID:12782123 Di-n-octyl phthalate decreases expression ISO Bcl2l11 (Mus musculus) 6480464 di-n-octyl phthalate results in decreased expression of BCL2L11 protein CTD PMID:29128616 diarsenic trioxide increases expression ISO BCL2L11 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of BCL2L11 mRNA and Arsenic Trioxide results in increased expression of BCL2L11 protein CTD PMID:17203211 more ... diarsenic trioxide affects expression ISO BCL2L11 (Homo sapiens) 6480464 Arsenic Trioxide affects the expression of BCL2L11 protein CTD PMID:36509116 diarsenic trioxide increases degradation ISO BCL2L11 (Homo sapiens) 6480464 Arsenic Trioxide results in increased degradation of BCL2L11 protein CTD PMID:36509116 diarsenic trioxide multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased degradation of BCL2L11 protein] more ... CTD PMID:21655183 more ... dibenzo[a,l]pyrene increases methylation ISO Bcl2l11 (Mus musculus) 6480464 dibenzo(a and l)pyrene results in increased methylation of BCL2L11 gene CTD PMID:28476633 dibutyl phthalate decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of BCL2L11 mRNA CTD PMID:17361019 and PMID:21266533 diclofenac affects expression ISO BCL2L11 (Homo sapiens) 6480464 Diclofenac affects the expression of BCL2L11 mRNA CTD PMID:24752500 dicrotophos increases expression ISO BCL2L11 (Homo sapiens) 6480464 dicrotophos results in increased expression of BCL2L11 mRNA CTD PMID:28302478 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of BCL2L11 mRNA CTD PMID:22546817 diepoxybutane increases expression ISO BCL2L11 (Homo sapiens) 6480464 diepoxybutane results in increased expression of BCL2L11 mRNA CTD PMID:29792945 dinophysistoxin 1 increases expression ISO BCL2L11 (Homo sapiens) 6480464 dinophysistoxin 1 results in increased expression of BCL2L11 mRNA CTD PMID:28939011 dioxygen multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein more ... CTD PMID:25472572 dioxygen multiple interactions EXP 6480464 [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BCL2L11 mRNA] and [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of BCL2L11 mRNA CTD PMID:33729688 diquat increases expression ISO Bcl2l11 (Mus musculus) 6480464 Diquat results in increased expression of BCL2L11 mRNA CTD PMID:26785375 and PMID:27057282 diquat multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 procyanidin B2 inhibits the reaction [Diquat results in increased expression of BCL2L11 mRNA] CTD PMID:27057282 dorsomorphin multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:35530161 doxorubicin multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Doxorubicin] results in decreased phosphorylation of BCL2L11 protein more ... CTD PMID:17339365 and PMID:20856197 doxorubicin multiple interactions EXP 6480464 5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1 more ... CTD PMID:32075913 doxorubicin increases expression ISO BCL2L11 (Homo sapiens) 6480464 Doxorubicin results in increased expression of BCL2L11 protein CTD PMID:25339540 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of BCL2L11 mRNA and Doxorubicin results in increased expression of BCL2L11 protein CTD PMID:26318906 and PMID:32075913 doxorubicin decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of BCL2L11 protein CTD PMID:17339365 efavirenz increases expression ISO BCL2L11 (Homo sapiens) 6480464 efavirenz metabolite results in increased expression of BCL2L11 mRNA more ... CTD PMID:21958719 efavirenz increases response to substance ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 protein results in increased susceptibility to efavirenz metabolite CTD PMID:21958719 elemental selenium multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with Selenium] more ... CTD PMID:17339365 elemental selenium increases expression ISO BCL2L11 (Homo sapiens) 6480464 Selenium results in increased expression of BCL2L11 protein CTD PMID:17339365 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of BCL2L11 mRNA CTD PMID:29391264 enniatin decreases expression EXP 6480464 enniatins results in decreased expression of BCL2L11 mRNA CTD PMID:27163883 entinostat decreases expression ISO BCL2L11 (Homo sapiens) 6480464 entinostat results in decreased expression of BCL2L11 mRNA CTD PMID:26272509 entinostat multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA CTD PMID:27188386 epichlorohydrin decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Epichlorohydrin results in decreased expression of BCL2L11 mRNA CTD PMID:29792945 epoxiconazole increases expression ISO Bcl2l11 (Mus musculus) 6480464 epoxiconazole results in increased expression of BCL2L11 mRNA CTD PMID:35436446 erlotinib hydrochloride increases expression ISO BCL2L11 (Homo sapiens) 6480464 Erlotinib Hydrochloride results in increased expression of BCL2L11 protein CTD PMID:30171258 erlotinib hydrochloride multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 Harmine promotes the reaction [Erlotinib Hydrochloride results in increased expression of BCL2L11 protein] CTD PMID:30171258 ethanol increases expression ISO Bcl2l11 (Mus musculus) 6480464 Ethanol results in increased expression of BCL2L11 mRNA CTD PMID:24095927 ethanol multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Ethanol co-treated with FOXO3 protein] results in increased expression of BCL2L11 mRNA more ... CTD PMID:26470730 ethyl methanesulfonate increases expression ISO BCL2L11 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of BCL2L11 mRNA CTD PMID:23649840 ferric oxide increases expression ISO Bcl2l11 (Mus musculus) 6480464 ferric oxide analog results in increased expression of BCL2L11 mRNA and ferric oxide analog results in increased expression of BCL2L11 protein CTD PMID:24525745 and PMID:25086211 flutamide increases expression EXP 6480464 Flutamide results in increased expression of BCL2L11 mRNA and Flutamide results in increased expression of BCL2L11 protein CTD PMID:20850791 and PMID:24793618 flutamide increases expression ISO Bcl2l11 (Mus musculus) 6480464 Flutamide results in increased expression of BCL2L11 protein CTD PMID:16301331 flutamide multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 CBL protein affects the reaction [Flutamide results in increased expression of BCL2L11 protein] CTD PMID:16301331 fluvastatin multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of BCL2L11 mRNA CTD PMID:16996129 folic acid affects expression ISO BCL2L11 (Homo sapiens) 6480464 Folic Acid affects the expression of BCL2L11 mRNA CTD PMID:16361273 formaldehyde increases expression ISO BCL2L11 (Homo sapiens) 6480464 Formaldehyde results in increased expression of BCL2L11 mRNA CTD PMID:23649840 furan increases expression EXP 6480464 furan results in increased expression of BCL2L11 mRNA CTD PMID:20562052 more ... furosemide affects expression EXP 6480464 Furosemide affects the expression of BCL2L11 mRNA CTD PMID:17497460 gallic acid decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Gallic Acid results in decreased expression of BCL2L11 mRNA CTD PMID:29205955 gefitinib increases response to substance ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 protein results in increased susceptibility to gefitinib CTD PMID:20237869 gemcitabine increases expression ISO BCL2L11 (Homo sapiens) 6480464 Gemcitabine results in increased expression of BCL2L11 mRNA CTD PMID:17039268 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of BCL2L11 mRNA CTD PMID:33387578 Gingerenone A increases expression ISO BCL2L11 (Homo sapiens) 6480464 gingerenone A results in increased expression of BCL2L11 protein modified form CTD PMID:26242912 glucose multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] and resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] CTD PMID:25471227 glucose increases expression EXP 6480464 Glucose results in increased expression of BCL2L11 protein CTD PMID:25471227 gold atom decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Gold analog results in decreased expression of BCL2L11 mRNA CTD PMID:36057382 gold(0) decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Gold analog results in decreased expression of BCL2L11 mRNA CTD PMID:36057382 gossypol increases expression ISO BCL2L11 (Homo sapiens) 6480464 Gossypol results in increased expression of BCL2L11 protein CTD PMID:18840529 GW 6471 multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 GW 6471 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L11 protein] CTD PMID:37979351 halothane increases expression ISO Bcl2l11 (Mus musculus) 6480464 Halothane results in increased expression of BCL2L11 mRNA CTD PMID:32795494 halothane multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Ryanodine co-treated with Halothane] results in increased expression of BCL2L11 mRNA and Dantrolene inhibits the reaction [Halothane results in increased expression of BCL2L11 mRNA] CTD PMID:32795494 harmine multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 Harmine promotes the reaction [Erlotinib Hydrochloride results in increased expression of BCL2L11 protein] CTD PMID:30171258 hydrogen peroxide increases expression ISO Bcl2l11 (Mus musculus) 6480464 Hydrogen Peroxide results in increased expression of BCL2L11 mRNA CTD PMID:27057282 hydrogen peroxide multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 procyanidin B2 inhibits the reaction [Hydrogen Peroxide results in increased expression of BCL2L11 mRNA] CTD PMID:27057282 ibrutinib multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 ibrutinib promotes the reaction [(+)-JQ1 compound results in increased expression of BCL2L11 protein] CTD PMID:26254443 icariin affects expression EXP 6480464 icariin affects the expression of BCL2L11 protein CTD PMID:25472572 icariin multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein] CTD PMID:25472572 indometacin multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L11 mRNA CTD PMID:28628672 isoflurane decreases expression EXP 6480464 Isoflurane results in decreased expression of BCL2L11 mRNA CTD PMID:16978161 isoprenaline increases expression ISO Bcl2l11 (Mus musculus) 6480464 Isoproterenol results in increased expression of BCL2L11 protein CTD PMID:14996839 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of BCL2L11 mRNA CTD PMID:24286936 isoprenaline increases expression ISO BCL2L11 (Homo sapiens) 6480464 Isoproterenol results in increased expression of BCL2L11 mRNA CTD PMID:24286936 ketoconazole increases expression ISO Bcl2l11 (Mus musculus) 6480464 Ketoconazole results in increased expression of BCL2L11 mRNA CTD PMID:25808816 lead diacetate increases expression ISO Bcl2l11 (Mus musculus) 6480464 lead acetate results in increased expression of BCL2L11 mRNA CTD PMID:21829687 lovastatin multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [Lovastatin results in increased expression of BCL2L11 protein] CTD PMID:18766339 lovastatin multiple interactions EXP 6480464 Lovastatin inhibits the reaction [Cholesterol and Dietary results in increased expression of BCL2L11 protein] CTD PMID:35734936 lovastatin increases expression ISO BCL2L11 (Homo sapiens) 6480464 Lovastatin results in increased expression of BCL2L11 protein CTD PMID:18766339 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] CTD PMID:25471227 LY294002 increases expression ISO BCL2L11 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of BCL2L11 protein alternative form CTD PMID:21179458 LY294002 multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rebamipide results in decreased expression of BCL2L11 protein] more ... CTD PMID:20856197 more ... maneb increases expression ISO BCL2L11 (Homo sapiens) 6480464 Maneb results in increased expression of BCL2L11 protein CTD PMID:18266926 maneb multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Paraquat co-treated with Maneb] results in increased expression of BCL2L11 protein CTD PMID:18266926 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of BCL2L11 protein CTD PMID:25732873 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of BCL2L11 mRNA CTD PMID:28801915 medroxyprogesterone acetate multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of BCL2L11 protein CTD PMID:16709600 melatonin multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA] CTD PMID:35643323 mercury atom decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Mercury results in decreased expression of BCL2L11 mRNA CTD PMID:19937285 mercury dibromide decreases expression ISO BCL2L11 (Homo sapiens) 6480464 mercuric bromide results in decreased expression of BCL2L11 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA CTD PMID:27188386 mercury(0) decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Mercury results in decreased expression of BCL2L11 mRNA CTD PMID:19937285 methamphetamine increases expression ISO BCL2L11 (Homo sapiens) 6480464 Methamphetamine results in increased expression of BCL2L11 protein CTD PMID:23820845 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of BCL2L11 protein CTD PMID:34214594 methamphetamine multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of BCL2L11 protein] and DDIT3 protein affects the reaction [Methamphetamine results in increased expression of BCL2L11 protein] CTD PMID:34214594 methamphetamine multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [N-Methyl-3 more ... CTD PMID:23820845 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of BCL2L11 gene CTD PMID:35440735 methyl methanesulfonate increases expression ISO BCL2L11 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of BCL2L11 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO BCL2L11 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of BCL2L11 mRNA CTD PMID:28001369 methylparaben increases expression ISO BCL2L11 (Homo sapiens) 6480464 methylparaben results in increased expression of BCL2L11 mRNA CTD PMID:24481588 methylseleninic acid multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with methylselenic acid] more ... CTD PMID:17339365 and PMID:18790785 methylseleninic acid increases expression ISO BCL2L11 (Homo sapiens) 6480464 methylselenic acid results in increased expression of BCL2L11 mRNA and methylselenic acid results in increased expression of BCL2L11 protein CTD PMID:17339365 and PMID:28161410 methylseleninic acid increases cleavage ISO BCL2L11 (Homo sapiens) 6480464 methylselenic acid results in increased cleavage of BCL2L11 protein CTD PMID:18790785 microcystin-LR increases expression ISO Bcl2l11 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of BCL2L11 mRNA CTD PMID:17654400 Mitotane increases expression EXP 6480464 Mitotane results in increased expression of BCL2L11 mRNA CTD PMID:23485034 MK-2206 multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [mirdametinib co-treated with MK 2206] results in increased expression of BCL2L11 protein more ... CTD PMID:27634878 mono(2-ethylhexyl) phthalate increases expression ISO Bcl2l11 (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L11 protein CTD PMID:37979351 mono(2-ethylhexyl) phthalate multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 GW 6471 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L11 protein] CTD PMID:37979351 monodansylcadaverine increases expression ISO BCL2L11 (Homo sapiens) 6480464 monodansylcadaverine results in increased expression of BCL2L11 protein CTD PMID:16170020 monosodium L-glutamate increases expression ISO Bcl2l11 (Mus musculus) 6480464 Sodium Glutamate results in increased expression of BCL2L11 mRNA CTD PMID:19001666 monosodium L-glutamate multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of BCL2L11 mRNA CTD PMID:19001666 morphine increases expression ISO BCL2L11 (Homo sapiens) 6480464 Morphine results in increased expression of BCL2L11 protein CTD PMID:19292871 N-acetyl-L-cysteine multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [[Bortezomib co-treated with romidepsin] results in increased expression of BCL2L11 protein] CTD PMID:15173094 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arsenic Trioxide results in increased degradation of BCL2L11 protein] CTD PMID:36509116 N-methyl-4-phenylpyridinium increases expression ISO BCL2L11 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 mRNA CTD PMID:18266926 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L11 mRNA CTD PMID:28801915 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 MIR181C mRNA inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 mRNA] and MIR181C mRNA inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 protein] CTD PMID:28770951 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 mRNA and 1-Methyl-4-phenylpyridinium results in increased expression of BCL2L11 protein CTD PMID:28770951 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions EXP 6480464 [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein and S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein] CTD PMID:16030430 N-nitrosodiethylamine increases expression ISO Bcl2l11 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of BCL2L11 mRNA CTD PMID:24535843 nickel atom multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of BCL2L11 mRNA] CTD PMID:14575637 nickel atom affects expression ISO BCL2L11 (Homo sapiens) 6480464 Nickel affects the expression of BCL2L11 mRNA CTD PMID:14575637 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of BCL2L11 mRNA CTD PMID:22110744 nickel sulfate increases expression ISO BCL2L11 (Homo sapiens) 6480464 nickel sulfate results in increased expression of BCL2L11 mRNA CTD PMID:17382205 nicotinamide multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Berberine co-treated with Niacinamide] results in increased expression of BCL2L11 mRNA and Niacinamide promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in increased expression of BCL2L11 protein] CTD PMID:25472572 and PMID:26712469 nicotinamide increases expression ISO BCL2L11 (Homo sapiens) 6480464 Niacinamide results in increased expression of BCL2L11 mRNA CTD PMID:26712469 nimustine increases expression ISO BCL2L11 (Homo sapiens) 6480464 Nimustine results in increased expression of BCL2L11 mRNA and Nimustine results in increased expression of BCL2L11 protein CTD PMID:26418950 nimustine multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 mutant form inhibits the reaction [Nimustine results in increased cleavage of CASP9 protein] and pyrazolanthrone inhibits the reaction [Nimustine results in increased expression of BCL2L11 mRNA] CTD PMID:26418950 NORCANTHARIDIN increases expression ISO BCL2L11 (Homo sapiens) 6480464 norcantharidin results in increased expression of BCL2L11 protein alternative form CTD PMID:29193574 ochratoxin A decreases expression ISO BCL2L11 (Homo sapiens) 6480464 ochratoxin A results in decreased expression of BCL2L11 mRNA CTD PMID:30559759 and PMID:30763683 okadaic acid increases expression ISO BCL2L11 (Homo sapiens) 6480464 Okadaic Acid results in increased expression of BCL2L11 mRNA CTD PMID:28939011 omipalisib multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [trametinib co-treated with omipalisib] results in increased expression of BCL2L11 protein CTD PMID:22733540 osthole increases expression ISO BCL2L11 (Homo sapiens) 6480464 osthol results in increased expression of BCL2L11 protein alternative form CTD PMID:29319219 ozone multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BCL2L11 mRNA more ... CTD PMID:32699268 and PMID:32845096 ozone multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of BCL2L11 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid decreases expression ISO BCL2L11 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in decreased expression of BCL2L11 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA CTD PMID:27188386 paclitaxel affects response to substance ISO Bcl2l11 (Mus musculus) 6480464 BCL2L11 protein affects the susceptibility to Paclitaxel CTD PMID:17652622 panobinostat decreases expression ISO BCL2L11 (Homo sapiens) 6480464 panobinostat results in decreased expression of BCL2L11 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 (+)-JQ1 compound promotes the reaction [Panobinostat results in increased expression of BCL2L11 protein] more ... CTD PMID:24435446 and PMID:27188386 panobinostat increases expression ISO BCL2L11 (Homo sapiens) 6480464 panobinostat results in increased expression of BCL2L11 protein CTD PMID:24435446 paracetamol multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of BCL2L11 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BCL2L11 mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of BCL2L11 mRNA CTD PMID:33387578 paracetamol decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of BCL2L11 mRNA CTD PMID:26690555 paracetamol increases expression ISO BCL2L11 (Homo sapiens) 6480464 Acetaminophen results in increased expression of BCL2L11 mRNA CTD PMID:21420995 and PMID:25704631 paracetamol affects expression ISO Bcl2l11 (Mus musculus) 6480464 Acetaminophen affects the expression of BCL2L11 mRNA CTD PMID:17562736 paraquat decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Paraquat results in decreased expression of BCL2L11 mRNA CTD PMID:18836921 paraquat multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Paraquat co-treated with Maneb] results in increased expression of BCL2L11 protein CTD PMID:18266926 paraquat increases expression ISO BCL2L11 (Homo sapiens) 6480464 Paraquat results in increased expression of BCL2L11 protein CTD PMID:18266926 paraquat multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 FOXO3 mutant form inhibits the reaction [Paraquat results in increased expression of BCL2L11 mRNA] CTD PMID:23620592 paraquat increases expression ISO Bcl2l11 (Mus musculus) 6480464 Paraquat results in increased expression of BCL2L11 mRNA CTD PMID:23620592 patulin increases expression ISO BCL2L11 (Homo sapiens) 6480464 Patulin results in increased expression of BCL2L11 mRNA CTD PMID:21844328 PD 0325901 increases expression ISO BCL2L11 (Homo sapiens) 6480464 mirdametinib results in increased expression of BCL2L11 protein CTD PMID:24576621 and PMID:27634878 PD 0325901 multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [mirdametinib co-treated with MK 2206] results in increased expression of BCL2L11 protein more ... CTD PMID:24576621 and PMID:27634878 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 FOXO3 protein affects the reaction [perfluorooctane sulfonic acid results in increased expression of BCL2L11 protein] CTD PMID:31588057 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of BCL2L11 protein CTD PMID:31588057 perfluorooctanoic acid increases expression ISO BCL2L11 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of BCL2L11 protein CTD PMID:35123991 pevonedistat affects expression ISO BCL2L11 (Homo sapiens) 6480464 pevonedistat affects the expression of BCL2L11 mRNA and pevonedistat affects the expression of BCL2L11 protein CTD PMID:24634471 phenobarbital decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Phenobarbital results in decreased expression of BCL2L11 mRNA CTD PMID:19270015 phenobarbital affects expression ISO Bcl2l11 (Mus musculus) 6480464 Phenobarbital affects the expression of BCL2L11 mRNA CTD PMID:23091169 phenobarbital increases expression ISO Bcl2l11 (Mus musculus) 6480464 Phenobarbital results in increased expression of BCL2L11 mRNA CTD PMID:25270620 phenylmercury acetate decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of BCL2L11 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA CTD PMID:27188386 phloretin multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 Phloretin inhibits the reaction [[cobaltous chloride co-treated with lipopolysaccharide and E coli O55-B5] results in increased expression of BCL2L11 protein] CTD PMID:32408695 picoxystrobin decreases expression ISO BCL2L11 (Homo sapiens) 6480464 picoxystrobin results in decreased expression of BCL2L11 mRNA CTD PMID:33512557 pinostrobin increases expression ISO BCL2L11 (Homo sapiens) 6480464 pinostrobin results in increased expression of BCL2L11 mRNA CTD PMID:37777166 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of BCL2L11 mRNA CTD PMID:12832660 ponatinib multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 (+)-JQ1 compound promotes the reaction [ponatinib results in increased expression of BCL2L11 protein] and ponatinib promotes the reaction [(+)-JQ1 compound results in increased expression of BCL2L11 protein] CTD PMID:25053825 ponatinib increases expression ISO BCL2L11 (Homo sapiens) 6480464 ponatinib results in increased expression of BCL2L11 protein CTD PMID:25053825 potassium chromate increases expression ISO BCL2L11 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of BCL2L11 mRNA CTD PMID:17382205 Pramanicin affects response to substance ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 protein affects the susceptibility to pramanicin CTD PMID:23441183 Pramanicin increases expression ISO BCL2L11 (Homo sapiens) 6480464 pramanicin analog results in increased expression of BCL2L11 protein CTD PMID:23441183 proanthocyanidin decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Proanthocyanidins results in decreased expression of BCL2L11 mRNA CTD PMID:29205955 prochloraz increases expression EXP 6480464 prochloraz results in increased expression of BCL2L11 mRNA CTD PMID:29038839 procyanidin B2 multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 procyanidin B2 inhibits the reaction [Diquat results in increased expression of BCL2L11 mRNA] and procyanidin B2 inhibits the reaction [Hydrogen Peroxide results in increased expression of BCL2L11 mRNA] CTD PMID:27057282 propylparaben increases expression ISO BCL2L11 (Homo sapiens) 6480464 propylparaben results in increased expression of BCL2L11 mRNA CTD PMID:24481588 protein kinase inhibitor multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of BCL2L11 mRNA] CTD PMID:28003376 pyrethrins increases expression ISO BCL2L11 (Homo sapiens) 6480464 Pyrethrins results in increased expression of BCL2L11 mRNA CTD PMID:35321623 quercetin increases expression ISO BCL2L11 (Homo sapiens) 6480464 Quercetin results in increased expression of BCL2L11 mRNA and Quercetin results in increased expression of BCL2L11 protein CTD PMID:25339540 and PMID:30152185 quercetin decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Quercetin results in decreased expression of BCL2L11 protein CTD PMID:20438634 quizartinib multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 (+)-JQ1 compound promotes the reaction [quizartinib results in increased expression of BCL2L11 protein] and quizartinib promotes the reaction [(+)-JQ1 compound results in increased expression of BCL2L11 protein] CTD PMID:25053825 quizartinib increases expression ISO BCL2L11 (Homo sapiens) 6480464 quizartinib results in increased expression of BCL2L11 protein CTD PMID:25053825 raloxifene increases expression ISO BCL2L11 (Homo sapiens) 6480464 Raloxifene Hydrochloride results in increased expression of BCL2L11 mRNA CTD PMID:19429434 reactive oxygen species multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [[[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased phosphorylation of and results in increased stability of TP53 protein] which results in decreased expression of BCL2L11 protein CTD PMID:27634759 Rebamipide decreases expression ISO BCL2L11 (Homo sapiens) 6480464 rebamipide results in decreased expression of BCL2L11 protein CTD PMID:29054700 Rebamipide multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rebamipide results in decreased expression of BCL2L11 protein] more ... CTD PMID:29054700 remdesivir increases expression ISO BCL2L11 (Homo sapiens) 6480464 remdesivir results in increased expression of BCL2L11 protein CTD PMID:35417658 resveratrol multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 protein promotes the reaction [resveratrol results in increased activity of BAK1 protein] more ... CTD PMID:21179458 more ... resveratrol multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]] and resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] CTD PMID:25471227 resveratrol increases expression ISO Bcl2l11 (Mus musculus) 6480464 resveratrol results in increased expression of BCL2L11 protein CTD PMID:20026400 and PMID:21980390 resveratrol increases expression ISO BCL2L11 (Homo sapiens) 6480464 resveratrol results in increased expression of BCL2L11 protein and resveratrol results in increased expression of BCL2L11 protein alternative form CTD PMID:17636462 more ... resveratrol increases response to substance ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 protein results in increased susceptibility to resveratrol CTD PMID:22245142 romidepsin multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Bortezomib co-treated with romidepsin] results in increased expression of BCL2L11 protein more ... CTD PMID:15173094 and PMID:27634878 romidepsin increases expression ISO BCL2L11 (Homo sapiens) 6480464 romidepsin results in increased expression of BCL2L11 protein CTD PMID:15069698 more ... rotenone increases expression EXP 6480464 Rotenone results in increased expression of BCL2L11 mRNA CTD PMID:28374803 rotenone decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Rotenone results in decreased expression of BCL2L11 mRNA CTD PMID:33512557 and PMID:36586010 ryanodine multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Ryanodine co-treated with Halothane] results in increased expression of BCL2L11 mRNA CTD PMID:32795494 S-allylcysteine multiple interactions EXP 6480464 S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein] CTD PMID:16030430 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [sodium arsenite results in increased phosphorylation of BCL2L11 protein] CTD PMID:16818494 SB 431542 multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Se-methyl-L-selenocysteine increases expression ISO BCL2L11 (Homo sapiens) 6480464 selenomethylselenocysteine metabolite results in increased expression of BCL2L11 mRNA CTD PMID:25321483 Se-methylselenocysteine increases expression ISO BCL2L11 (Homo sapiens) 6480464 selenomethylselenocysteine metabolite results in increased expression of BCL2L11 mRNA CTD PMID:25321483 selenium atom multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with Selenium] more ... CTD PMID:17339365 selenium atom increases expression ISO BCL2L11 (Homo sapiens) 6480464 Selenium results in increased expression of BCL2L11 protein CTD PMID:17339365 selumetinib increases expression ISO BCL2L11 (Homo sapiens) 6480464 AZD 6244 results in increased expression of BCL2L11 protein CTD PMID:22729845 serpentine asbestos multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 PRKD1 protein affects the reaction [Asbestos more ... CTD PMID:19116364 serpentine asbestos decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Asbestos and Serpentine results in decreased expression of BCL2L11 protein CTD PMID:19116364 silicon dioxide decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of BCL2L11 mRNA and Silicon Dioxide results in decreased expression of BCL2L11 mRNA CTD PMID:25351596 and PMID:25895662 silicon dioxide decreases methylation ISO BCL2L11 (Homo sapiens) 6480464 Silicon Dioxide results in decreased methylation of BCL2L11 gene CTD PMID:34973136 silicon dioxide increases expression ISO Bcl2l11 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of BCL2L11 mRNA CTD PMID:19073995 sirolimus multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Cisplatin inhibits the reaction [[Sirolimus results in increased phosphorylation of AKT1 protein] which results in increased phosphorylation of FOXO3 protein]] which results in increased expression of BCL2L11 protein more ... CTD PMID:21092744 and PMID:29054700 sirolimus decreases expression ISO Bcl2l11 (Mus musculus) 6480464 Sirolimus results in decreased expression of BCL2L11 protein CTD PMID:18097008 sirolimus increases expression ISO BCL2L11 (Homo sapiens) 6480464 Sirolimus results in increased expression of BCL2L11 protein CTD PMID:21092744 sodium arsenite increases expression ISO Bcl2l11 (Mus musculus) 6480464 sodium arsenite results in increased expression of BCL2L11 mRNA CTD PMID:16166651 sodium arsenite increases response to substance EXP 6480464 BCL2L11 protein results in increased susceptibility to sodium arsenite CTD PMID:16818494 sodium arsenite increases phosphorylation EXP 6480464 sodium arsenite results in increased phosphorylation of BCL2L11 protein CTD PMID:16818494 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of BCL2L11 protein alternative form CTD PMID:20830294 sodium arsenite decreases expression ISO Bcl2l11 (Mus musculus) 6480464 sodium arsenite results in decreased expression of BCL2L11 mRNA CTD PMID:19822182 sodium arsenite multiple interactions EXP 6480464 SB 203580 inhibits the reaction [sodium arsenite results in increased phosphorylation of BCL2L11 protein] more ... CTD PMID:16818494 and PMID:20830294 sodium arsenite multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 CEP-11004 inhibits the reaction [sodium arsenite results in increased expression of BCL2L11 protein] more ... CTD PMID:16166651 sodium chloride multiple interactions EXP 6480464 [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein and S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein] CTD PMID:16030430 sodium chromate multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA and Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in increased expression of BCL2L11 mRNA] CTD PMID:35643323 sorafenib affects localization ISO BCL2L11 (Homo sapiens) 6480464 sorafenib affects the localization of BCL2L11 protein CTD PMID:18200035 sorafenib increases expression ISO BCL2L11 (Homo sapiens) 6480464 sorafenib results in increased expression of BCL2L11 protein CTD PMID:18200035 sorafenib decreases expression ISO BCL2L11 (Homo sapiens) 6480464 sorafenib results in decreased expression of BCL2L11 protein CTD PMID:16109713 sorafenib multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [sorafenib co-treated with 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3 and 2-d)pyrimidine] results in increased expression of BCL2L11 protein CTD PMID:23036488 streptozocin increases expression ISO Bcl2l11 (Mus musculus) 6480464 Streptozocin results in increased expression of BCL2L11 mRNA CTD PMID:33524429 streptozocin multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 Chlorpyrifos promotes the reaction [Streptozocin results in increased expression of BCL2L11 mRNA] CTD PMID:33524429 succimer multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BCL2L11 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BCL2L11 mRNA CTD PMID:21641980 and PMID:26378955 succimer multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BCL2L11 mRNA CTD PMID:26378955 sunitinib increases expression ISO BCL2L11 (Homo sapiens) 6480464 Sunitinib results in increased expression of BCL2L11 mRNA CTD PMID:31533062 tamoxifen multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 Tamoxifen promotes the reaction [methylselenic acid results in increased cleavage of BCL2L11 protein] CTD PMID:18790785 tanespimycin increases expression ISO BCL2L11 (Homo sapiens) 6480464 tanespimycin results in increased expression of BCL2L11 protein CTD PMID:24784839 taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [sodium arsenite results in increased expression of BCL2L11 protein alternative form] CTD PMID:20830294 temozolomide increases expression ISO BCL2L11 (Homo sapiens) 6480464 temozolomide results in increased expression of BCL2L11 mRNA and temozolomide results in increased expression of BCL2L11 protein CTD PMID:26418950 temozolomide multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 BCL2L11 mutant form inhibits the reaction [temozolomide results in increased cleavage of CASP9 protein] and pyrazolanthrone inhibits the reaction [temozolomide results in increased expression of BCL2L11 mRNA] CTD PMID:26418950 testosterone increases expression EXP 6480464 Testosterone deficiency results in increased expression of BCL2L11 protein CTD PMID:20850791 testosterone decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Testosterone results in decreased expression of BCL2L11 mRNA CTD PMID:33359661 tetrachloromethane increases expression ISO Bcl2l11 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of BCL2L11 mRNA and Carbon Tetrachloride results in increased expression of BCL2L11 protein CTD PMID:17482686 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of BCL2L11 mRNA CTD PMID:33387578 tetrachloromethane multiple interactions ISO Bcl2l11 (Mus musculus) 6480464 PLG protein affects the reaction [Carbon Tetrachloride results in increased expression of BCL2L11 protein] CTD PMID:17482686 tetrathiomolybdate(2-) multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in increased cleavage of BCL2L11 protein and [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of BCL2L11 protein CTD PMID:22276220 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BCL2L11 mRNA CTD PMID:23411599 and PMID:34492290 trametinib multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [trametinib co-treated with omipalisib] results in increased expression of BCL2L11 protein CTD PMID:22733540 trametinib increases expression ISO BCL2L11 (Homo sapiens) 6480464 trametinib results in increased expression of BCL2L11 protein CTD PMID:22733540 Tributyltin oxide increases expression ISO Bcl2l11 (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in increased expression of BCL2L11 mRNA CTD PMID:22434021 trichostatin A multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:14575637 and PMID:27188386 trichostatin A decreases expression ISO BCL2L11 (Homo sapiens) 6480464 trichostatin A results in decreased expression of BCL2L11 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A increases expression ISO BCL2L11 (Homo sapiens) 6480464 trichostatin A results in increased expression of BCL2L11 mRNA CTD PMID:24935251 trimellitic anhydride increases expression ISO Bcl2l11 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of BCL2L11 mRNA CTD PMID:19042947 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of BCL2L11 mRNA CTD PMID:30589522 triptonide increases expression ISO Bcl2l11 (Mus musculus) 6480464 triptonide results in increased expression of BCL2L11 mRNA CTD PMID:33045310 troglitazone decreases expression ISO Bcl2l11 (Mus musculus) 6480464 troglitazone results in decreased expression of BCL2L11 mRNA CTD PMID:28973697 tunicamycin multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [Tunicamycin results in increased expression of BCL2L11 protein] CTD PMID:36509116 tunicamycin increases expression ISO BCL2L11 (Homo sapiens) 6480464 Tunicamycin results in increased expression of BCL2L11 protein CTD PMID:36509116 urethane increases expression ISO BCL2L11 (Homo sapiens) 6480464 Urethane results in increased expression of BCL2L11 mRNA CTD PMID:28818685 valproic acid increases expression ISO BCL2L11 (Homo sapiens) 6480464 Valproic Acid results in increased expression of BCL2L11 mRNA CTD PMID:32623605 valproic acid multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:32623605 valproic acid decreases expression ISO BCL2L11 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of BCL2L11 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO Bcl2l11 (Mus musculus) 6480464 Valproic Acid affects the expression of BCL2L11 mRNA CTD PMID:17963808 valsartan multiple interactions EXP 6480464 Valsartan inhibits the reaction [Cyclophosphamide results in increased expression of BCL2L11 mRNA] CTD PMID:32197949 vemurafenib multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [BRAF protein mutant form results in increased susceptibility to vemurafenib] which results in increased expression of BCL2L11 protein and [MET protein affects the susceptibility to HGF protein] affects the reaction [[BRAF protein mutant form results in increased susceptibility to vemurafenib] which results in increased expression of BCL2L11 protein] CTD PMID:27689874 vorinostat multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:19509267 and PMID:27188386 vorinostat increases expression EXP 6480464 Vorinostat results in increased expression of BCL2L11 mRNA and Vorinostat results in increased expression of BCL2L11 protein CTD PMID:17331788 vorinostat increases expression ISO BCL2L11 (Homo sapiens) 6480464 vorinostat results in increased expression of BCL2L11 mRNA more ... CTD PMID:16144943 more ... withaferin A decreases expression ISO BCL2L11 (Homo sapiens) 6480464 withaferin A results in decreased expression of BCL2L11 protein CTD PMID:20438634 withaferin A multiple interactions EXP 6480464 withaferin A inhibits the reaction [Cholesterol and Dietary results in increased expression of BCL2L11 protein] CTD PMID:35734936 xanthohumol increases expression ISO BCL2L11 (Homo sapiens) 6480464 xanthohumol results in increased expression of BCL2L11 alternative form CTD PMID:35229981 zinc atom increases expression ISO BCL2L11 (Homo sapiens) 6480464 Zinc results in increased expression of BCL2L11 mRNA CTD PMID:19071009 zinc protoporphyrin increases expression ISO BCL2L11 (Homo sapiens) 6480464 zinc protoporphyrin results in increased expression of BCL2L11 protein CTD PMID:27829220 zinc(0) increases expression ISO BCL2L11 (Homo sapiens) 6480464 Zinc results in increased expression of BCL2L11 mRNA CTD PMID:19071009 zoledronic acid multiple interactions ISO BCL2L11 (Homo sapiens) 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of BCL2L11 mRNA CTD PMID:16996129